This month’s edition features two articles that examine the Exchange-related guidance and future policy priorities recently announced by the Centers for Medicare and Medicaid Services (CMS) in the second final Notice of Benefit and Payment Parameters for 2022 and Pharmacy Benefit ...
This month’s edition of Health Policy News features a recent PCG white paper on Syndromic Surveillance—a tool that has been central to helping state and local health departments track the spread of COVID-19 and target testing, contact tracing, and other ...
This month, we provide updates on topics covered in recent editions, including an update on the latest health policy developments relative to the COVID-19 public health emergency, digital healthcare access barriers and inequities that have come to light during the ...
In the month since the presidential inauguration, the Biden administration has been busy putting its mark on U.S. health policy. A new Marketplace Open Enrollment Period has begun, and the administration has promulgated guidance and executive orders, weighed in on ...
Introduction To date, the COVID-19 vaccination effort has been largely successful for the United States; however, vaccine hesitancy is a major factor preventing the nation from reaching herd immunity. The ...
As we noted in the recent recent Health Policy News overview of the second Final Notice of Benefit and Payment Parameters (NBPP) for 2022, the process of finalizing Exchange guidance ...
On April 30th, The Centers for Medicare and Medicaid Services (CMS) released the second final Notice of Benefit and Payment Parameters for 2022 and Pharmacy Benefit Manager Standards (NBPP), as well ...
The past month brought the fifth renewal[1] of the U.S. COVID-19 Public Health Emergency (PHE), as well as the start of the American Rescue Plan Act of 2021 (ARP)’s implementation. ...
The COVID-19 pandemic has impacted many state policy efforts over the last year, with state agencies across the U.S. re-deploying their staff towards tracing and vaccination work. This has undoubtedly contributed to less momentum on drug importation efforts at the state ...
The COVID-19 pandemic has underscored the need to capture and securely share patient information via health information exchanges (HIE). HIEs across the nation have been critically important in helping healthcare ...
California has long been an innovator in prescription drug cost control efforts. In 2017, the state passed SB 17, a piece of drug pricing legislation with multiple reporting requirements aimed ...
The COVID-19 pandemic accelerated the digitization of healthcare services, as safety precautions prompted a transition of care delivery from in-person to virtual. The health risks posed by the COVID-19 virus ...
The American Rescue Plan Act of 2021 (the Act) was signed into law on March 11, 2021. This sweeping law provides funding to address the impact of the COVID-19 pandemic ...
Over the past three decades, an overreliance on quality measures as a material driving factor in value-based payment (VBP) arrangements has created an adverse trade-off within delivery systems: achieve short ...
